Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

NCT01877590 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Coronary Artery Disease
Left Ventricular Mass

Interventions

DRUG: alpha-lipoic acid

Sponsor

Wuhan General Hospital of Guangzhou Military Command